Goldshleger Ilya

Track

Insider profile

Performance

Overall performance
1.6
Performance over holding periods
1.6
30 days 90 days 120 days
Average return 13% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Goldshleger Ilya's trades of Rxsight Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-03 2024-11-29
US Rxsight Inc (RXST)
PlS Planned sale
23,148 -28.1%
231.45
US$4,062,886 		23,148 -28.1% 231.45 US$4,062,886
2024-11-29 2024-11-29
US Rxsight Inc (RXST)
PrS Proposed sale
8,113
326.79
US$127,773 		8,113 326.79 US$127,773
2024-11-26 2024-11-26
US Rxsight Inc (RXST)
PrS Proposed sale
82,153
245.27
US$3,239,306 		82,153 245.27 US$3,239,306
2024-11-26 2024-11-26
US Rxsight Inc (RXST)
PlS Planned sale
3,100 -6.8%
45.88
US$142,228 		3,100 -6.8% 45.88 US$142,228
2024-11-26 2024-11-22
US Rxsight Inc (RXST)
PlS Planned sale
3,100 -6.8%
45.00
US$139,500 		3,100 -6.8% 45.00 US$139,500
2024-11-22 2024-11-22
US Rxsight Inc (RXST)
PrS Proposed sale
3,100
45.00
US$139,500 		3,100 45.00 US$139,500
2024-11-18 2024-11-18
US Rxsight Inc (RXST)
PrS Proposed sale
3,100
45.00
US$139,502 		3,100 45.00 US$139,502
2024-11-18 2024-11-18
US Rxsight Inc (RXST)
PlS Planned sale
33 -0.1%
45.07
US$1,487 		33 -0.1% 45.07 US$1,487
2024-11-18 2024-11-18
US Rxsight Inc (RXST)
PlS Planned sale
3,067 -6.8%
45.00
US$138,015 		3,067 -6.8% 45.00 US$138,015
2024-11-18 2024-11-15
US Rxsight Inc (RXST)
PlS Planned sale
4,875 -10.3%
46.00
US$224,250 		4,875 -10.3% 46.00 US$224,250
2024-11-15 2024-11-15
US Rxsight Inc (RXST)
PrS Proposed sale
4,875
46.00
US$224,250 		4,875 46.00 US$224,250
2024-11-14 2024-11-12
US Rxsight Inc (RXST)
PlS Planned sale
1,330 -3.1%
46.13
US$61,356 		1,330 -3.1% 46.13 US$61,356
2024-11-12 2024-11-12
US Rxsight Inc (RXST)
PrS Proposed sale
1,330
46.13
US$61,356 		1,330 46.13 US$61,356
2024-11-08 2024-11-07
US Rxsight Inc (RXST)
PlS Planned sale
200 -0.5%
55.53
US$11,106 		200 -0.5% 55.53 US$11,106
2024-11-08 2024-11-07
US Rxsight Inc (RXST)
PlS Planned sale
2,900 -6.4%
54.96
US$159,389 		2,900 -6.4% 54.96 US$159,389
2024-11-07 2024-11-07
US Rxsight Inc (RXST)
PrS Proposed sale
3,100
55.00
US$170,494 		3,100 55.00 US$170,494
2024-11-05 2024-11-04
US Rxsight Inc (RXST)
PlS Planned sale
260 -0.6%
51.74
US$13,452 		260 -0.6% 51.74 US$13,452
2024-11-05 2024-11-04
US Rxsight Inc (RXST)
PlS Planned sale
2,840 -6.3%
50.98
US$144,795 		2,840 -6.3% 50.98 US$144,795
2024-11-04 2024-11-04
US Rxsight Inc (RXST)
PrS Proposed sale
3,100
51.05
US$158,247 		3,100 51.05 US$158,247
2024-10-31 2024-10-30
US Rxsight Inc (RXST)
PlS Planned sale
3,105 -6.8%
51.91
US$161,171 		3,105 -6.8% 51.91 US$161,171
2024-10-30 2024-10-30
US Rxsight Inc (RXST)
PrS Proposed sale
3,105
51.91
US$161,171 		3,105 51.91 US$161,171
2024-10-28 2024-10-28
US Rxsight Inc (RXST)
PrS Proposed sale
3,100
50.64
US$156,993 		3,100 50.64 US$156,993
2024-10-28 2024-10-28
US Rxsight Inc (RXST)
PlS Planned sale
3,100 -6.8%
50.64
US$156,993 		3,100 -6.8% 50.64 US$156,993
2024-10-28 2024-10-25
US Rxsight Inc (RXST)
PlS Planned sale
3,100 -6.8%
49.79
US$154,360 		3,100 -6.8% 49.79 US$154,360
2024-10-25 2024-10-25
US Rxsight Inc (RXST)
PrS Proposed sale
3,100
49.79
US$154,360 		3,100 49.79 US$154,360
2024-10-22 2024-10-22
US Rxsight Inc (RXST)
PrS Proposed sale
3,100
49.68
US$154,001 		3,100 49.68 US$154,001
2024-10-22 2024-10-22
US Rxsight Inc (RXST)
PlS Planned sale
3,100 -6.8%
49.68
US$154,001 		3,100 -6.8% 49.68 US$154,001
2024-10-18 2024-10-18
US Rxsight Inc (RXST)
PrS Proposed sale
3,105
50.09
US$155,533 		3,105 50.09 US$155,533
2024-10-18 2024-10-18
US Rxsight Inc (RXST)
PlS Planned sale
34 -0.1%
50.59
US$1,720 		34 -0.1% 50.59 US$1,720
2024-10-18 2024-10-18
US Rxsight Inc (RXST)
PlS Planned sale
69 -0.2%
50.57
US$3,489 		69 -0.2% 50.57 US$3,489
2024-10-18 2024-10-18
US Rxsight Inc (RXST)
PlS Planned sale
3,002 -6.6%
50.07
US$150,324 		3,002 -6.6% 50.07 US$150,324
2024-10-18 2024-10-16
US Rxsight Inc (RXST)
PlS Planned sale
3,100 -6.8%
49.78
US$154,318 		3,100 -6.8% 49.78 US$154,318
2024-10-16 2024-10-16
US Rxsight Inc (RXST)
PrS Proposed sale
3,100
49.78
US$154,317 		3,100 49.78 US$154,317
2024-10-15 2024-10-14
US Rxsight Inc (RXST)
PrS Proposed sale
3,100
50.09
US$155,268 		3,100 50.09 US$155,268
2024-10-15 2024-10-14
US Rxsight Inc (RXST)
PlS Planned sale
3,100 -6.8%
50.09
US$155,268 		3,100 -6.8% 50.09 US$155,268
2024-10-15 2024-10-11
US Rxsight Inc (RXST)
PlS Planned sale
3,100 -6.8%
50.19
US$155,594 		3,100 -6.8% 50.19 US$155,594
2024-10-11 2024-10-11
US Rxsight Inc (RXST)
PrS Proposed sale
3,100
50.19
US$155,593 		3,100 50.19 US$155,593
2024-10-15 2024-10-10
US Rxsight Inc (RXST)
PlS Planned sale
3,105 -6.8%
48.82
US$151,596 		3,105 -6.8% 48.82 US$151,596
2024-10-10 2024-10-10
US Rxsight Inc (RXST)
PrS Proposed sale
3,105
48.82
US$151,595 		3,105 48.82 US$151,595
2024-10-08 2024-10-08
US Rxsight Inc (RXST)
PrS Proposed sale
3,100
48.26
US$149,612 		3,100 48.26 US$149,612
2024-10-08 2024-10-08
US Rxsight Inc (RXST)
PlS Planned sale
3,100 -6.8%
48.26
US$149,612 		3,100 -6.8% 48.26 US$149,612
2024-10-08 2024-10-04
US Rxsight Inc (RXST)
PlS Planned sale
206 -0.5%
48.65
US$10,022 		206 -0.5% 48.65 US$10,022
2024-10-08 2024-10-04
US Rxsight Inc (RXST)
PlS Planned sale
28 -0.1%
48.47
US$1,357 		28 -0.1% 48.47 US$1,357
2024-10-08 2024-10-04
US Rxsight Inc (RXST)
PlS Planned sale
2,866 -6.3%
47.96
US$137,445 		2,866 -6.3% 47.96 US$137,445
2024-10-04 2024-10-04
US Rxsight Inc (RXST)
PrS Proposed sale
3,100
48.01
US$148,824 		3,100 48.01 US$148,824